Maryland State Retirement & Pension System’s Enanta Pharmaceuticals ENTA Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,967	Closed	-$322K	–	1571
2023 Q1	$322K	Hold	7,967	–	–	0.01%	1298
2022 Q4	$371K	Hold	7,967	–	–	0.01%	1178
2022 Q3	$413K	Buy	7,967 +564	+8%	+$33K	0.03%	375
2022 Q2	$350K	Buy	7,403 +126	+2%	+$6.84K	0.01%	1183
2022 Q1	$518K	Buy	7,277 +143	+2%	+$9.3K	0.01%	1050
2021 Q4	$533K	Buy	7,134 +55	+0.8%	+$4.32K	0.01%	1057
2021 Q3	$399K	Buy	+7,079	New	+$350K	0.01%	1219

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Maryland State Retirement & Pension System's ENTA Position: Q2 2023 in Review

Maryland State Retirement & Pension System sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 7,967 shares — an estimated $322K sold.

Maryland State Retirement & Pension System first reported a position in ENTA in Q3 2021 and held it in 7 quarters. The position peaked at $533K in Q4 2021. 133 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

Maryland State Retirement & Pension System reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Maryland State Retirement & Pension System sold 7,967 Enanta Pharmaceuticals shares in Q2 2023, an estimated $322K.
Maryland State Retirement & Pension System first reported a position in Enanta Pharmaceuticals in Q3 2021 and held it in 7 quarters.
Maryland State Retirement & Pension System's Enanta Pharmaceuticals position peaked at $533K in Q4 2021.
133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2023, filed 11 Jul 2023.